Shopping Cart 0
Cart Subtotal
AED 0

RedHill Biopharma Ltd (RDHL)-Medical Equipment-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs for the treatment of inflammatory and gastrointestinal diseases and cancer. The company's pipeline products include oral combination therapy candidates for the treatment of helicobacter pylori infection, crohn's disease and multiple sclerosis; uPA inhibitor for the treatment of gastrointestinal and other solid tumor cancers; Hsp27 inhibitor for the treatment of pancreatic and other gastrointestinal cancers; oral thin film formulation of rizatriptan which is intended for the treatment of acute migraines. Its products under development also intended for the treatment of bowel cleanser, IBS-D, and other indications. RedHill is headquartered in Tel Aviv, Israel.

RedHill Biopharma Ltd (RDHL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

RedHill Biopharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

RedHill Biopharma Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6

RedHill Biopharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

RedHill Biopharma Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

RedHill Biopharma Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

RedHill Biopharma Ltd, Medical Equipment, Deal Details 10

Partnerships 10

RedHill Biopharma Enters Into Licensing Agreement With UCF Research Foundation 10

RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 10

Equity Offering 11

RedHill Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of ADSs and Warrants for USD1.4 Million 11

RedHill Biopharma Withdraws Public Offering of ADSs 13

RedHill Biopharma Raises USD40 Million in Public Offering of American Depository Shares 14

RedHill Biopharma Raises USD12.5 Million in Public Offering of American Depository Shares 15

RedHill Biopharma Completes Private Placement Of Shares And Warrants For US$11.7 Million 16

RedHill Biopharma Completes Private Placement Of Units For US$8.5 Million 18

RedHill Biopharma Ltd-Key Competitors 20

Key Employees 21

Locations And Subsidiaries 22

Head Office 22

Recent Developments 23

Financial Announcements 23

Feb 23, 2017: RedHill Biopharma Reports 2016 Fourth Quarter and Full-Year Financial Results 23

Nov 14, 2016: RedHill Biopharma Reports 2016 Third Quarter Financial Results 25

Jul 26, 2016: RedHill Biopharma Reports 2016 Second Quarter Financial Results 28

Apr 20, 2016: RedHill Biopharma Reports 2016 First Quarter Financial Results 31

Feb 25, 2016: RedHill Biopharma Reports 2015 Fourth Quarter and Full-Year Financial Results 33

Corporate Communications 37

Feb 17, 2016: RedHill Biopharma Appoints Dr. June S. Almenoff and Ms. Theresa M. Stevens to Advisory Board 37

Other Significant Developments 38

Aug 11, 2016: RedHill Biopharma Provides 2016 Semi-Annual R&D Update 38

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

RedHill Biopharma Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

RedHill Biopharma Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

RedHill Biopharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

RedHill Biopharma Ltd, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

RedHill Biopharma Ltd, Medical Equipment, Key Facts, 2015 1

RedHill Biopharma Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

RedHill Biopharma Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6

RedHill Biopharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

RedHill Biopharma Ltd, Deals By Market, 2011 to YTD 2017 8

RedHill Biopharma Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

RedHill Biopharma Enters Into Licensing Agreement With UCF Research Foundation 10

RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 10

RedHill Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of ADSs and Warrants for USD1.4 Million 11

RedHill Biopharma Withdraws Public Offering of ADSs 13

RedHill Biopharma Raises USD40 Million in Public Offering of American Depository Shares 14

RedHill Biopharma Raises USD12.5 Million in Public Offering of American Depository Shares 15

RedHill Biopharma Completes Private Placement Of Shares And Warrants For US$11.7 Million 16

RedHill Biopharma Completes Private Placement Of Units For US$8.5 Million 18

RedHill Biopharma Ltd, Key Competitors 20

RedHill Biopharma Ltd, Key Employees 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs for the treatment of inflammatory and gastrointestinal diseases and cancer. The company's pipeline products include oral combination therapy candidates for the treatment of helicobacter pylori infection, crohn's disease and multiple sclerosis; uPA inhibitor for the treatment of gastrointestinal and other solid tumor cancers; Hsp27 inhibitor for the treatment of pancreatic and other gastrointestinal cancers; oral thin film formulation of rizatriptan which is intended for the treatment of acute migraines. Its products under development also intended for the treatment of bowel cleanser, IBS-D, and other indications. RedHill is headquartered in Tel Aviv, Israel.

RedHill Biopharma Ltd (RDHL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

RedHill Biopharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

RedHill Biopharma Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6

RedHill Biopharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

RedHill Biopharma Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

RedHill Biopharma Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

RedHill Biopharma Ltd, Medical Equipment, Deal Details 10

Partnerships 10

RedHill Biopharma Enters Into Licensing Agreement With UCF Research Foundation 10

RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 10

Equity Offering 11

RedHill Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of ADSs and Warrants for USD1.4 Million 11

RedHill Biopharma Withdraws Public Offering of ADSs 13

RedHill Biopharma Raises USD40 Million in Public Offering of American Depository Shares 14

RedHill Biopharma Raises USD12.5 Million in Public Offering of American Depository Shares 15

RedHill Biopharma Completes Private Placement Of Shares And Warrants For US$11.7 Million 16

RedHill Biopharma Completes Private Placement Of Units For US$8.5 Million 18

RedHill Biopharma Ltd-Key Competitors 20

Key Employees 21

Locations And Subsidiaries 22

Head Office 22

Recent Developments 23

Financial Announcements 23

Feb 23, 2017: RedHill Biopharma Reports 2016 Fourth Quarter and Full-Year Financial Results 23

Nov 14, 2016: RedHill Biopharma Reports 2016 Third Quarter Financial Results 25

Jul 26, 2016: RedHill Biopharma Reports 2016 Second Quarter Financial Results 28

Apr 20, 2016: RedHill Biopharma Reports 2016 First Quarter Financial Results 31

Feb 25, 2016: RedHill Biopharma Reports 2015 Fourth Quarter and Full-Year Financial Results 33

Corporate Communications 37

Feb 17, 2016: RedHill Biopharma Appoints Dr. June S. Almenoff and Ms. Theresa M. Stevens to Advisory Board 37

Other Significant Developments 38

Aug 11, 2016: RedHill Biopharma Provides 2016 Semi-Annual R&D Update 38

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

RedHill Biopharma Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

RedHill Biopharma Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

RedHill Biopharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

RedHill Biopharma Ltd, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

RedHill Biopharma Ltd, Medical Equipment, Key Facts, 2015 1

RedHill Biopharma Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

RedHill Biopharma Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

RedHill Biopharma Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6

RedHill Biopharma Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

RedHill Biopharma Ltd, Deals By Market, 2011 to YTD 2017 8

RedHill Biopharma Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

RedHill Biopharma Enters Into Licensing Agreement With UCF Research Foundation 10

RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 10

RedHill Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of ADSs and Warrants for USD1.4 Million 11

RedHill Biopharma Withdraws Public Offering of ADSs 13

RedHill Biopharma Raises USD40 Million in Public Offering of American Depository Shares 14

RedHill Biopharma Raises USD12.5 Million in Public Offering of American Depository Shares 15

RedHill Biopharma Completes Private Placement Of Shares And Warrants For US$11.7 Million 16

RedHill Biopharma Completes Private Placement Of Units For US$8.5 Million 18

RedHill Biopharma Ltd, Key Competitors 20

RedHill Biopharma Ltd, Key Employees 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com